Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer.
about
The thyroid imaging reporting and data system on US, but not the BRAFV600E mutation in fine-needle aspirates, is associated with lateral lymph node metastasis in PTC.2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerRisk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma.Optimal Cut-Off Values of Lymph Node Ratio Predicting Recurrence in Papillary Thyroid Cancer.Clinical features of Hispanic thyroid cancer cases and the role of known genetic variants on disease riskPreferential Use of Total Thyroidectomy without Prophylactic Central Lymph Node Dissection for Early-Stage Papillary Thyroid Cancer: Oncologic Outcomes in an Integrated Health Plan.To Identify Predictors of Central Lymph Node Metastasis in Patients with Clinically Node-Negative Conventional Papillary Thyroid Carcinoma.Preoperative Lymph Node Staging by FDG PET/CT With Contrast Enhancement for Thyroid Cancer: A Multicenter Study and Comparison With Neck CTA novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors.Sporadic Small (≤20 mm) Nonfunctioning Pancreatic Neuroendocrine Neoplasm: is the Risk of Malignancy Negligible When Adopting a More Conservative Strategy? A Systematic Review and Meta-analysis.Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome.Therapeutic options in papillary thyroid carcinoma: current guidelines and future perspectives.Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients.Gastric cancer: texture analysis from multidetector computed tomography as a potential preoperative prognostic biomarker.The Impact of Pathologically Positive Lymph Nodes in the Clinically Negative Neck: An Analysis of 39,301 Patients with Papillary Thyroid Cancer.Defining a Hospital Volume Threshold for Minimally Invasive Pancreaticoduodenectomy in the United States.Differentiated and Medullary Thyroid Cancer: Surgical Management of Cervical Lymph Nodes.Surgical management of papillary thyroid carcinoma: an overview.Surgical approach to level VI in papillary thyroid carcinoma: an overview.A nomogram predicting contralateral central neck lymph node metastasis for papillary thyroid carcinoma.Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.Optimal cut-off age in the TNM Staging system of differentiated thyroid cancer: is 55 years better than 45 years?Patterns and clinical significance of cervical lymph node metastasis in papillary thyroid cancer patients with Delphian lymph node metastasis.2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinomaDifferentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.Racial/ethnic differences in thyroid cancer incidence in the United States, 2007-2014.Therapeutic lateral neck dissection in well-differentiated thyroid cancer: Analysis on factors predicting distribution of positive nodes and prognosis.Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma.The Flip Side of NIFTP: an Increase in Rates of Unfavorable Histologic Parameters in the Remainder of Papillary Thyroid Carcinomas.Detailed Lymph Node Sectioning of Papillary Thyroid Carcinoma Specimen Increases the Number of pN1a Patients.Prognostic Value of the Number of Retrieved Lymph Nodes in Pathological Nx or N0 Classical Papillary Thyroid Carcinoma.Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why?Clinical behaviors of rare variants of papillary thyroid carcinoma are associated with survival: a population-level analysis.Integrated Characterization of MicroRNA and mRNA Transcriptome in Papillary Thyroid Carcinoma.Is biopsy enough for papillary thyroid microcarcinoma?: An analysis of the SEER database 2004 to 2013 with propensity score matching
P2860
Q30364216-F22A5769-4C49-46C8-AF11-23BD44440AC7Q30367068-9B8964E5-FB28-4F2B-81A2-A90F1CFD6014Q30374928-6687B516-3240-47C6-8F22-DA403129355FQ36566991-579804D2-9E1A-4CE7-B4CC-E06F8A23AAB6Q37175876-9B53BA18-F590-4CA1-8E6E-6DADD20C9AC0Q37401945-20C27F8C-FA6E-41D3-8957-A0E2BE9B3394Q37542581-C625AC78-DBF4-4A36-A72A-D711F62DD4A7Q37668375-C853152B-A874-420A-8BB9-E88FC4D2D6EBQ37725502-43447A0C-63CA-4C97-AC42-50172BC64265Q38691825-6B582CDF-7137-4DE2-BFC4-4A73C1F2ECE9Q38711054-DF5BC55E-20F8-41F9-A0DE-D3B8CDBD08B5Q38844362-22DACCC5-8E49-41D6-859D-5D5D6093E002Q38879184-89D08890-A70C-4F5E-863F-0AE2F560FA76Q38935234-B1C2B645-161E-4C71-8759-6D51F53A24CCQ38996180-C03E432C-3773-45DD-9530-C0FCB06DF600Q39058160-D6803677-759B-491D-87AF-6F883775B8E5Q39091665-453D1138-7DCB-4D86-A24F-BBF2F12C9FD2Q39239856-D47907CD-A27E-4BC4-8A8A-4670B1111876Q39371366-CD05BED5-21A8-4FA3-BA08-0F2176F3B54CQ39383999-3001F8C5-5F34-47D2-B03E-3883A29B3925Q39819035-0F9C1503-50A5-4EAF-A13A-C1B0311D6DA6Q40498172-7B99A63A-2813-4208-8D8C-1BC643C74268Q41343104-DD553FBD-0FEA-4489-8AA3-3C22FF8D8830Q41514177-0DD2DBFA-5F6F-4F21-8F8B-C97984EE0936Q48088071-992F6770-51C5-40D4-A33C-A2ACCB7A36BEQ48234858-32BD5FC6-0484-40E8-860A-3AF3165D67DBQ48265221-B4F2796D-DABB-45DA-B0FA-50CFF8B25868Q52860267-D891E79A-2491-459B-AF3C-EB9368D8000AQ52894575-5E3607C9-769E-41ED-B0E6-BFB8611F0083Q53088180-42A70623-DD9D-47E5-A9F7-C0A39EF75F9EQ53154422-E51195B2-822E-412B-8568-A969281FC06BQ54857387-64775390-5B5A-4F83-B398-31C9B56CB452Q54983052-BBDE7A80-E2E7-4C88-8FA0-5F65F2BC8B01Q55371926-95A80966-845E-4D44-ADDF-193C268678EDQ58802129-32AFED60-2731-4688-8E3D-E523D3100333
P2860
Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Presence and Number of Lymph N ...... With Papillary Thyroid Cancer.
@en
type
label
Presence and Number of Lymph N ...... With Papillary Thyroid Cancer.
@en
prefLabel
Presence and Number of Lymph N ...... With Papillary Thyroid Cancer.
@en
P2093
P356
P1476
Presence and Number of Lymph N ...... With Papillary Thyroid Cancer.
@en
P2093
Julie A Sosa
Michaela A Dinan
Mohamed Abdelgadir Adam
Paolo Goffredo
Randall P Scheri
Sanziana A Roman
Shelby D Reed
Terry Hyslop
P304
P356
10.1200/JCO.2014.59.8391
P407
P577
2015-06-15T00:00:00Z